|
1
|
De Rosa AF, Cecchin GV, Kujaruk MR, Gayet
EG, Grasso LE and Rigou DG: Malignant mesothelioma of the
pericardium. Medicina (B Aires). 54:49–52. 1994.(In Spanish).
PubMed/NCBI
|
|
2
|
Thomason R, Schlegel W, Lucca M, Cummings
S and Lee S: Primary malignant mesothelioma of the pericardium.
Case report and literature review. Tex Heart Inst J. 21:170–174.
1994.PubMed/NCBI
|
|
3
|
Falkenstern-Ge RF, Kimmich M, Bode-Erdmann
S, Friedel G, Ott G and Kohlhäufl M: Pleural mesothelioma
presenting as periumbilical metastasis: The first clinical
documentation. Case Rep Oncol Med. 2013:1987292013.PubMed/NCBI
|
|
4
|
Nilsson A and Rasmuson T: Primary
Pericardial mesothelioma: Report of a patient and literature
review. Case Rep Oncol. 2:125–132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Eren NT and Akar AR: Primary pericardial
mesothelioma. Curr Treat Options Oncol. 3:369–373. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Makarawate P, Chaosuwannakit N,
Chindaprasirt J, Ungarreevittaya P, Chaiwiriyakul S, Wirasorn K,
Kuptarnond C and Sawanyawisuth K: Malignant mesothelioma of the
pericardium: A report of two different presentations. Case Rep
Oncol Med. 2013:3569012013.PubMed/NCBI
|
|
7
|
Choi WS, Im MS, Kang JH, Kim YG, Hwang IC,
Lee JM, Lee S, Shin HS, Lee SP and Cho GY: Primary malignant
pericardial mesothelioma presenting as acute pericarditis. J
Cardiovasc Ultrasound. 20:57–59. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nana A, Vorilhon C, Adjtoutah D, Azarnoush
K, Kissel V, Chabin X, Chailloux A, Belhakem A, Tixier V, Ferrier
N, et al: Contribution of magnetic resonance imaging in diagnosis
of pericardial mesothelioma: A case report. Ann Cardiol Angeiol
(Paris). 61:370–374. 2012.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ost P, Rottey S, Smeets P, Boterberg T,
Stragier B and Goethals I: F-18 fluorodeoxyglucose PET/CT scanning
in the diagnostic work-up of a primary pericardial mesothelioma: A
case report. J Thorac Imaging. 23:35–38. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kaul TK, Fields BL and Kahn DR: Primary
malignant pericardial mesothelioma: A case report and review. J
Cardiovasc Surg (Torino). 35:261–267. 1994.PubMed/NCBI
|
|
11
|
Maruyama R, Sakai M, Nakamura T, Suemitsu
R, Okamoto T, Wataya H, Nishiyama K, Kamei T and Ichinose Y:
Triplet chemotherapy for malignant pericardial mesothelioma: A case
report. Jpn J Clin Oncol. 36:245–248. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fujita K, Hata M, Sezai A and Minami K:
Three-year survival after surgery for primary malignant pericardial
mesothelioma: Report of a case. Surg Today. 44:948–951. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Papi M, Genestreti G, Tassinari D,
Lorenzini P, Serra S, Ricci M, Pasquini E, Nicolini M, Pasini G,
Tamburini E, et al: Malignant pericardial mesothelioma. Report of
two cases, review of the literature and differential diagnosis.
Tumori. 91:276–279. 2005.PubMed/NCBI
|
|
14
|
Doval DC, Pande SB, Sharma JB, Rao SA,
Prakash N and Vaid AK: Report of a case of pericardial mesothelioma
with liver metastases responding well to pemetrexed and
platinum-based chemotherapy. J Thorac Oncol. 2:780–781. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bilchick KC and Wise RA: Paradoxical
physical findings described by Kussmaul: Pulsus paradoxus and
Kussmaul's sign. Lancet. 359:1940–1942. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Attanoos RL: Asbestos-related lung
disease. Surg Pathol Clin. 3:109–127. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fujiwara H, Kamimori T, Morinaga K, Takeda
Y, Kohyama N, Miki Y, Inai K and Yamamoto S: An autopsy case of
primary pericardial mesothelioma in arc cutter exposed to asbestos
through talc pencils. Ind Health. 43:346–350. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mensi C, Giacomini S, Sieno C, Consonni D
and Riboldi L: Pericardial mesothelioma and asbestos exposure. Int
J Hyg Environ Health. 214:276–279. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kayatta MO, Dineen SP, Sica G, Puskas JD
and Pickens A: Primary pericardial mesothelioma in a 19-year-old
presenting as pericarditis. Ann Thorac Surg. 96:680–681. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gong W, Ye X, Shi K and Zhao Q: Primary
malignant pericardial mesothelioma - a rare cause of superior vena
cava thrombosis and constrictive pericarditis. J Thorac Dis.
6:E272–E275. 2014.PubMed/NCBI
|
|
21
|
Molina Garrido MJ, Mora Rufete A,
Rodriguez-Lescure A, Cascon Perez JD, Ardoy F, Guillen Ponce C and
Carrato Mena A: Recurrent pericardial effusion as initial
manifestation of primary diffuse pericardial malignant
mesothelioma. Clin Transl Oncol. 8:694–696. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Butz T, Faber L, Langer C, Korfer J,
Lindner O, Tannapfel A, Muller KM, Meissner A, Plehn G, Trappe HJ,
et al: Primary malignant pericardial mesothelioma - a rare cause of
pericardial effusion and consecutive constrictive pericarditis: A
case report. J Med Case Rep. 3:92562009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vogelzang NJ, Rusthoven JJ, Symanowski J,
Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S,
Manegold C, et al: Phase III study of pemetrexed in combination
with cisplatin versus cisplatin alone in patients with malignant
pleural mesothelioma. J Clin Oncol. 21:2636–2644. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Santos C, Montesinos J, Castañer E, Sole
JM and Baga R: Primary pericardial mesothelioma. Lung Cancer.
60:291–293. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fujimoto N, Gemba K, Wada S, Ono K, Fujii
Y, Ozaki S, Ikeda T, Taguchi K, Kunitomo T and Kishimoto T:
Malignant pericardial mesothelioma with response to chemotherapy. J
Thorac Oncol. 4:1440–1441. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Niyikiza C, Hanauske AR, Rusthoven JJ,
Calvert AH, Allen R, Paoletti P and Bunn PA: Pemetrexed safety and
dosing strategy. Semin Oncol. 29(Suppl 18): 24–29. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Paz-Ares LG, de Marinis F, De diu M,
Thomas M, Pujol JL, Bidoli P, Molinier O, Sahoo TP, Laack E, Reck
M, et al: PARAMOUNT: Final overall survival results of the phase
III study of maintenance pemetrexed versus placebo immediately
after induction treatment with pemetrexed plus cisplatin for
advanced nonsquamous non-small-cell lung cancer. J Clin Oncol.
31:2895–2902. 2013. View Article : Google Scholar : PubMed/NCBI
|
